Lisa Olson

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Lisa Olson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa Olson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Magenta Therapeutics, Inc. Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney Stock Option (Right to Buy) 100,000 01 Aug 2022 Direct

Insider Reports Filed by Lisa Olson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNTH Magenta Therapeutics, Inc. 01 Aug 2022 1 $0 4 Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney 01 Aug 2022, 21:18
DNTH Magenta Therapeutics, Inc. 17 May 2022 1 $0 4 Title: Head of Research and Chief Scientific Officer 19 May 2022, 16:24
DNTH Magenta Therapeutics, Inc. 15 Feb 2022 1 $0 4 Title: Head of Research and Chief Scientific Officer 17 Feb 2022, 16:17
DNTH Magenta Therapeutics, Inc. 16 Sep 2021 1 -$38,603 4 Head of Research and Chief Scientific Officer 20 Sep 2021, 17:00
DNTH Magenta Therapeutics, Inc. 14 Sep 2021 1 $0 4 Head of Research and Chief Scientific Officer 16 Sep 2021, 19:43
DNTH Magenta Therapeutics, Inc. 02 Aug 2021 1 $0 4 Title: Head of Research and Chief Scientific Officer 03 Aug 2021, 16:39
DNTH Magenta Therapeutics, Inc. 20 Jul 2021 1 $0 4 Head of Research and Chief Scientific Officer 22 Jul 2021, 16:36